Aquilo Capital Management, LLC

10% Owner

2 companies

Weak

Trades Analyzed

12M Win Rate

4.0%

Avg 3M Return

-37.8%

Avg 12M Return

-83.3%

Aquilo Capital Management, LLC is a 10% Owner at PVLA with holdings across 2 companies. Recent SEC Form 4 filings include 12 buys and 2 sells.

Estimated insider holdings value: $454.6M based on current market prices.

Holdings by Company

PVLAJul 21, 2020

Current Shares3.68M

Value$445.81M

Net Activity-1,900,000

Bought: 0Sold: 1.90M

SPROSep 22, 2022

Current Shares3.42M

Value$8.75M

Net Activity-1,077,707

Bought: 1.49MSold: 2.57M

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 22, 2022	SPRO Spero Therapeutics, Inc.	10% Owner	Sell	1,901,796	$2.25	$4,279,611.54	-20.4%	-26.4%	-45.0%
Apr 26, 2022	SPRO Spero Therapeutics, Inc.	10% Owner	Buy	39,727	$5.24	$207,970.85	+0.8%	-85.0%	-67.0%
Mar 30, 2022	SPRO Spero Therapeutics, Inc.	10% Owner	Buy	50,000	$8.79	$439,420.00	+0.5%	-91.0%	-83.3%
Mar 14, 2022	SPRO Spero Therapeutics, Inc.	10% Owner	Buy	23,708	$7.63	$180,797.21	+0.2%	-87.2%	-81.5%
Feb 28, 2022	SPRO Spero Therapeutics, Inc.	10% Owner	Buy	44,833	$9.53	$427,227.11	+0.4%	-87.7%	-84.6%
Feb 18, 2022	SPRO Spero Therapeutics, Inc.	10% Owner	Buy	14,828	$9.24	$137,038.89	+0.3%	-84.4%	-81.5%
Jan 31, 2022	SPRO Spero Therapeutics, Inc.	10% Owner	Buy	125,000	$11.59	$1,448,262.50	+2.5%	-57.1%	-84.4%
Jan 24, 2022	SPRO Spero Therapeutics, Inc.	10% Owner	Buy	1,599	$10.89	$17,418.07	-	-52.7%	-84.2%
Jan 18, 2022	SPRO Spero Therapeutics, Inc.	10% Owner	Buy	48,488	$12.41	$601,963.97	+1.0%	-54.5%	-84.9%
Jan 10, 2022	SPRO Spero Therapeutics, Inc.	10% Owner	Buy	8,867	$12.93	$114,608.64	+0.2%	-48.7%	-85.7%